OPEN TO THE FUTURE OF HEALTH RESEARCH
DAY 1 - 21st September
-
SESSION #0
-
SESSION #1
15.15 h - SESSION #1: OPEN TO IDEAS: Exploring new roads towards treatment opportunities
1 h 45'
Scientific research has achieved remarkable complexity, reaching a transformative revolution in medicine. However, the underlying biology of many diseases remains an enigma and eludes conventional therapies. Can we challenge existing paradigms and explore unconventional strategies to address unmet therapeutic needs?
Moderator: Quentin Cooper#1.1. New therapies
Speakers-
Mariona Graupera, Institut de Recerca contra la Leucèmia Josep Carreras (IJC), Barcelona.
-
Juan Miguel Redondo, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid.
-
María Jesús Vicent Docón, Centro de Investigación Príncipe Felipe (CIPF), Valencia.
-
Miguel Antonio López Pérez, Centro de Investigación en Medicina Molecular y Enfermedades Crónicas (CiMUS), Universidad de Santiago de Compostela, Santiago de Compostela.
#1.2. Novel approaches
Speakers-
Pau Gorostiza, Institut de Bioenginyeria de Catalunya (IBEC), Barcelona.
-
Miguel Che Parreira Soares, Fundação Calouste Gulbenkian, Lisbon.
-
Carmen María Fernández-Martos, Universidad San Pablo-CEU, Madrid.
-
Marc Claret, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona.
-
-
SESSION #2
17 h - SESSION #2: OPEN TO CHANGE. Innovative approaches to improve research assessment. The experience of ”la Caixa” Foundation applying AI tools
45'
Achieving fair and quality evaluation processes is increasingly complex, partly due to the high number of submitted proposals and their specificity. How can AI help us improve these processes? The team at ”la Caixa” Foundation will share lessons learned applying AI tools in our competitive calls.
Moderator: Quentin Cooper
DAY 2 - 22nd September
-
SESSION #3A
9.15 h - SESSION #3A: OPEN TO PATIENTS: is science ready for personalized medicine? What will be the role of patients in the future?
1 h 30'
What does health research need in order to be translational? How is the relationship between basic researchers and clinical researchers changing the future? Is there a need for bidirectional or even tridirectional approaches? What is the best strategy?
Moderator: Helena F. Florindo
Speakers-
María Abad, Vall d'Hebron Institut d'Oncologia (VHIO), Barcelona.
-
José Jalife, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid.
-
Oscar Vilarroya, Universitat Autònoma de Barcelona (UAB), Barcelona.
-
Carmen Gil, Centro de Investigaciones Biológicas. Consejo Superior de Investigaciones Científicas (CIB-CSIC), Madrid.
-
Raúl Mendez, Institut de Recerca Biomèdica (IRB Barcelona).
-
-
SESSION #3B
9.15 h - SESSION #3B: OPEN TO SOCIETY. Maximizing social impact in health research: new approaches
1 h 30'
How to achieve meaningful and impactful stakeholder engagement in health research? What are the challenges? What are the benefits for researchers and for research itself? What is the role/responsibility of individual researchers and research institutions to enable society engagement?
Moderator: Michela Bertero
Speakers-
Blanca Fuentes, Hospital La Paz Institute for Health Research-IdiPAZ, Madrid.
-
Frederic Bartumeus, Centre d’Estudis Avançats de Blanes. Consell Superior d'Investigacions Científiques (CEAB-CSIC), Girona.
-
Manuel Carreiras, Basque Center on Cognition, Brain and Language (BCBL), Donostia.
-
Leonor Saúde, Instituto de Medicina Molecular (iMM), Lisbon.
-
-
SESSION #4
11.15 h - SESSION #4: OPEN TO LEAP AHEAD. What is the role of researchers and research institutions to foster innovation and knowledge transfer?
1 h 30'
What are the incentives and hurdles for researchers to push their results beyond scientific publications? What are the strategies research institutions are following to stimulate innovation and knowledge transfer? How can we learn from each other or even collaborate to improve efficiency, build talent and attract investment?
Moderator: Quentin Cooper
Speakers-
Luis Serrano, Centre de Regulació Genòmica (CRG), Barcelona.
-
María A. Blasco, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid.
-
Bruno Silva-Santos, Instituto de Medicina Molecular (iMM), Lisbon.
-
-
FINAL CONCLUSIONS
12.45 h - FINAL CONCLUSIONS AND CLOSING SPEECH